×
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.93 (-1.93%)
MSFT   258.91 (-2.26%)
META   163.36 (-3.62%)
GOOGL   2,248.35 (-2.95%)
AMZN   108.18 (-4.45%)
TSLA   703.63 (-4.24%)
NVDA   161.18 (-4.45%)
NIO   22.33 (-2.70%)
BABA   117.15 (-1.33%)
AMD   81.12 (-5.85%)
MU   58.66 (-0.20%)
CGC   3.61 (-4.75%)
T   20.70 (-0.38%)
GE   65.90 (-1.21%)
F   11.93 (-0.91%)
DIS   97.26 (+0.67%)
AMC   13.68 (-3.18%)
PFE   50.57 (-2.53%)
PYPL   72.50 (-4.53%)
NFLX   181.95 (-3.80%)
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.93 (-1.93%)
MSFT   258.91 (-2.26%)
META   163.36 (-3.62%)
GOOGL   2,248.35 (-2.95%)
AMZN   108.18 (-4.45%)
TSLA   703.63 (-4.24%)
NVDA   161.18 (-4.45%)
NIO   22.33 (-2.70%)
BABA   117.15 (-1.33%)
AMD   81.12 (-5.85%)
MU   58.66 (-0.20%)
CGC   3.61 (-4.75%)
T   20.70 (-0.38%)
GE   65.90 (-1.21%)
F   11.93 (-0.91%)
DIS   97.26 (+0.67%)
AMC   13.68 (-3.18%)
PFE   50.57 (-2.53%)
PYPL   72.50 (-4.53%)
NFLX   181.95 (-3.80%)
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.93 (-1.93%)
MSFT   258.91 (-2.26%)
META   163.36 (-3.62%)
GOOGL   2,248.35 (-2.95%)
AMZN   108.18 (-4.45%)
TSLA   703.63 (-4.24%)
NVDA   161.18 (-4.45%)
NIO   22.33 (-2.70%)
BABA   117.15 (-1.33%)
AMD   81.12 (-5.85%)
MU   58.66 (-0.20%)
CGC   3.61 (-4.75%)
T   20.70 (-0.38%)
GE   65.90 (-1.21%)
F   11.93 (-0.91%)
DIS   97.26 (+0.67%)
AMC   13.68 (-3.18%)
PFE   50.57 (-2.53%)
PYPL   72.50 (-4.53%)
NFLX   181.95 (-3.80%)
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.93 (-1.93%)
MSFT   258.91 (-2.26%)
META   163.36 (-3.62%)
GOOGL   2,248.35 (-2.95%)
AMZN   108.18 (-4.45%)
TSLA   703.63 (-4.24%)
NVDA   161.18 (-4.45%)
NIO   22.33 (-2.70%)
BABA   117.15 (-1.33%)
AMD   81.12 (-5.85%)
MU   58.66 (-0.20%)
CGC   3.61 (-4.75%)
T   20.70 (-0.38%)
GE   65.90 (-1.21%)
F   11.93 (-0.91%)
DIS   97.26 (+0.67%)
AMC   13.68 (-3.18%)
PFE   50.57 (-2.53%)
PYPL   72.50 (-4.53%)
NFLX   181.95 (-3.80%)
OTCMKTS:OCPNY

Olympus Stock Forecast, Price & News

$20.13
-0.07 (-0.35%)
(As of 06/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$19.85
▼
$20.33
50-Day Range
$16.98
▼
$21.69
52-Week Range
$16.80
▼
$24.26
Volume
151,857 shs
Average Volume
146,792 shs
Market Capitalization
$25.88 billion
P/E Ratio
25.16
Dividend Yield
0.78%
Price Target
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart

Receive OCPNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.

OCPNY Stock Forecast (MarketRank)

Overall MarketRank™

1.28 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
Olympus logo

About Olympus (OTCMKTS:OCPNY)

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

OCPNY Stock News Headlines

June 12, 2022 | americanbankingnews.com
Short Interest in Olympus Co. (OTCMKTS:OCPNY) Drops By 50.1%
June 4, 2022 | americanbankingnews.com
Olympus (OTCMKTS:OCPNY) Upgraded at Zacks Investment Research
June 4, 2022 | americanbankingnews.com
FY2024 EPS Estimates for Olympus Co. Boosted by Jefferies Financial Group (OTCMKTS:OCPNY)
June 3, 2022 | americanbankingnews.com
Analysts Issue Forecasts for Olympus Co.'s Q1 2023 Earnings (OTCMKTS:OCPNY)
April 23, 2022 | seekingalpha.com
ClearBridge Investments Global Growth Strategy Q1 2022 Commentary
April 14, 2022 | seekingalpha.com
ClearBridge International Growth ADR Strategy Portfolio Manager Commentary Q1 2022
February 3, 2022 | markets.businessinsider.com
Here's what to expect from Olympus's earnings
November 19, 2021 | finance.yahoo.com
Here's What Could Help Olympus Corp. (OCPNY) Maintain Its Recent Price Strength
November 16, 2021 | finance.yahoo.com
Olympus Corp. (OCPNY) Upgraded to Buy: Here's Why
November 13, 2021 | markets.businessinsider.com
Olympus Launches Venture Capital Fund To Strengthen Medtech Leadership
November 10, 2021 | markets.businessinsider.com
What Wall Street expects from OLYMPUS's earnings
November 8, 2021 | finance.yahoo.com
Thai Credit Retail Bank Weighing Bangkok IPO Next Year
November 5, 2021 | markets.businessinsider.com
Here's what Wall Street expects from Olympus's earnings
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Structural clay products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:OCPNY
CUSIP
N/A
CIK
N/A
Web
www.olympus-global.com
Phone
(133) 340-2111
Fax
813-3340-2062
Employees
31,557
Year Founded
1919

Company Calendar

Last Earnings
5/11/2022
Today
6/28/2022
Fiscal Year End
3/31/2023

Profitability

EPS (Most Recent Fiscal Year)
$0.80
Trailing P/E Ratio
25.16
Forward P/E Ratio
22.62
P/E Growth
1.84
Net Income
$1.03 billion
Net Margins
13.35%
Pretax Margin
17.25%
Return on Equity
25.01%
Return on Assets
9.24%

Debt

Debt-to-Equity Ratio
0.65
Current Ratio
1.85
Quick Ratio
1.40

Sales & Book Value

Annual Sales
$7.74 billion
Price / Sales
3.34
Cash Flow
$1.23 per share
Price / Cash Flow
16.34
Book Value
$3.50 per share
Price / Book
5.75

Miscellaneous

Outstanding Shares
1,285,890,000
Free Float
N/A
Market Cap
$25.88 billion
Optionable
Not Optionable
Beta
0.68

Social Links















Olympus Frequently Asked Questions

How has Olympus' stock price performed in 2022?

Olympus' stock was trading at $23.13 on January 1st, 2022. Since then, OCPNY stock has decreased by 13.0% and is now trading at $20.13.
View the best growth stocks for 2022 here.

Are investors shorting Olympus?

Olympus saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 69,100 shares, an increase of 56.0% from the May 31st total of 44,300 shares. Based on an average daily volume of 402,700 shares, the short-interest ratio is presently 0.2 days.
View Olympus' Short Interest.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) posted its earnings results on Wednesday, May, 11th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.10. The business had revenue of $2.06 billion for the quarter, compared to the consensus estimate of $2.08 billion. Olympus had a net margin of 13.35% and a trailing twelve-month return on equity of 25.01%.
View Olympus' earnings history.

Is Olympus a good dividend stock?

Olympus(OTCMKTS:OCPNY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.78%. The dividend payout ratio of Olympus is 20.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Olympus will have a dividend payout ratio of 17.58% next year. This indicates that Olympus will be able to sustain or increase its dividend.

Who are Olympus' key executives?

Olympus' management team includes the following people:
  • Mr. Yasuo Takeuchi, Pres, CEO, Representative Exec. Officer & Director (Age 65, Pay $934.6k)
  • Mr. Stefan Kaufmann, Exec. Officer, Chief Admin. Officer, Chief Strategy Officer, ESG Officer & Director (Age 54, Pay $1.59M)
  • Mr. Chikashi Takeda, Exec. Officer & CFO (Age 60)
  • Mr. Nacho Abia, COO & Exec. Officer (Age 54)
  • Andre Rogan, Exec. Officer & CTO
  • Stephen Kneebone, Corp. Officer & Chief Information Officer
  • Takaaki Sakurai, VP of Investor Relations
  • Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel
  • Shigeto Ohtsuki, Corp. Officer & HR Head
  • Tetsuo Kobayashi, Exec. Officer and Chief Manufacturing & Supply Officer

What is Olympus' stock symbol?

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of Olympus?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Olympus' stock price today?

One share of OCPNY stock can currently be purchased for approximately $20.13.

How much money does Olympus make?

Olympus (OTCMKTS:OCPNY) has a market capitalization of $25.88 billion and generates $7.74 billion in revenue each year. The company earns $1.03 billion in net income (profit) each year or $0.80 on an earnings per share basis.

How many employees does Olympus have?

Olympus employs 31,557 workers across the globe.

Does Olympus have any subsidiaries?

The following companies are subsidiares of Olympus: AVS Co Ltd, Aizu Olympus Co Ltd, Algram Group Ltd, Aomori Olympus Co Ltd, Arc Medical Design Limited, Image Stream Medical Inc, Nagano Olympus Co Ltd, Olympus (Beijing) Sales & Service Co Ltd, Olympus (China) Co Ltd, Olympus (GuangZhou) Industrial Co Ltd, Olympus (Malaysia) Sdn Bhd, Olympus (Thailand) Co Ltd, Olympus America Inc, Olympus America de Mexico SA de CV, Olympus Australia Pty Ltd, Olympus Austria Gesellschaft mbH, Olympus Belgium SA/NV, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group sro, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Digital System Design Corp, Olympus Estonia Oü, Olympus Europa SE & Co KG, Olympus Finland OY, Olympus France SAS, Olympus Hong Kong and China Limited, Olympus Iberia SAU, Olympus Ireland, Olympus Italia SRL, Olympus Korea Co Ltd, Olympus Latin America Inc, Olympus Logitex Co Ltd, Olympus MEA FZ-LLC, Olympus Medical Science Sales Corp, Olympus Medical Systems Corp, Olympus Medical Systems India Private Limited, Olympus Medical Systems Vietnam Co Ltd, Olympus Memory Works Corp, Olympus Moscow Limited Liability Company, Olympus NDT Canada Inc, Olympus Nederland BV, Olympus New Zealand Limited, Olympus Norge A/S, Olympus Optical do Brasil Ltda, Olympus Polska sp zoo, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc, Olympus Singapore Pte Ltd, Olympus Soft Imaging Solutions GmbH, Olympus Surgical Technologies America Inc, Olympus Surgical Technologies Europe (Olympus Winter & Ibe GmbH), Olympus Sverige AB, Olympus Systems Corporation, Olympus Taiwan Co Ltd, Olympus Terumo Biomaterials Corp, Olympus Trading (Shanghai) Limited, Olympus UK & Ireland, Olympus Vietnam Co Ltd, Olympus doo Beograd, Olympus-RMS Corp, Olympus-Supportmate Corp, Shirakawa Olympus Co Ltd, Sony Olympus Medical Solutions Inc, Tecnologias Opticas e Digitais Lda, and TmediX Corporation.
Read More

When was Olympus founded?

Olympus was founded in 1919.

How can I contact Olympus?

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The official website for Olympus is www.olympus-global.com. The company can be reached via phone at (133) 340-2111, via email at [email protected], or via fax at 813-3340-2062.

This page (OTCMKTS:OCPNY) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.